...
首页> 外文期刊>European journal of clinical pharmacology >Delayed warfarin induced skin necrosis in a patient with poor warfarin metabolizing activity due to interrupted warfarin therapy
【24h】

Delayed warfarin induced skin necrosis in a patient with poor warfarin metabolizing activity due to interrupted warfarin therapy

机译:由于华法林治疗中断,华法林代谢活性差的患者延迟出现华法林引起的皮肤坏死

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Warfarin-induced skin necrosis (WISN) is a rare but potentially devastating complication of oral anticoagulation occurring within 3-10 days of warfarin therapy. Potential causes of WISN include overdose of warfarin, drugs which affect liver function, acquired or hereditary protein C, protein S or antithrombin deficiency, factor V Leiden mutation, and lupus anticoagulants [1]. The dermatologic complications occur in 0.01 to 0.1 % of warfarin-treated patients [2].
机译:华法林诱导的皮肤坏死(WISN)是一种罕见但可能具有毁灭性的口服华法林治疗后3-10天内发生的口服抗凝并发症。 WISN的潜在原因包括过量服用华法令,影响肝功能的药物,获得性或遗传性蛋白C,蛋白S或抗凝血酶缺乏症,因子V莱顿突变和狼疮抗凝剂[1]。在华法林治疗的患者中,皮肤科并发症发生率为0.01%至0.1%[2]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号